Synthekine (Series A)

Funding Details
Awarder
Inbox
Date Award
September 17, 2020
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$82,000,000

Company Info
Traction
Lead programs have shown promising efficacy and tolerability in preclinical studies.
Founders
Debanjan Ray
Company Description
Synthekine is a development stage biotherapeutics company focused on the engineering of novel specific and potent cytokine therapies.
Market
Cytokine therapeutics for cancer and autoimmune disorders
Location
Menlo Park, California, USA
Coinvestors
Canaan Partners, Samsara BioCapital, The Column Group

Links